Continuous Performance Test for assessing cognition among patients with Parkinson diseases

Background: Many patients with Parkinson diseases are faced with constant attention disorders and evaluation of these disorders in these patients is important. Methods: A cross-sectional study was conducted on 80 patients with Parkinson disease and 80 healthy Iranian people aged 40 to 70. All partic...

Full description

Bibliographic Details
Main Author: Afsaneh Zarghi
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2015-04-01
Series:International Clinical Neuroscience Journal
Online Access:http://journals.sbmu.ac.ir/Neuroscience/article/download/9472/pdf_17
id doaj-ec6ab283b04a4e8c845e3ea5bc19364c
record_format Article
spelling doaj-ec6ab283b04a4e8c845e3ea5bc19364c2020-11-25T01:33:08ZengShahid Beheshti University of Medical SciencesInternational Clinical Neuroscience Journal2383-18712383-20962015-04-0122454910.22037/icnj.v2i2.9472icnj-3056Continuous Performance Test for assessing cognition among patients with Parkinson diseasesAfsaneh Zarghi0Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranBackground: Many patients with Parkinson diseases are faced with constant attention disorders and evaluation of these disorders in these patients is important. Methods: A cross-sectional study was conducted on 80 patients with Parkinson disease and 80 healthy Iranian people aged 40 to 70. All participants in the two groups of healthy and patients were examined by neurologists and psychiatrists. After completing the questionnaire, they were evaluated through computerized cognitive Continuous Performance Test. Results: There was significance difference between the two groups in age, sex and education status and in some variables of the test (p<0.05). Patients compared with healthy controls and showed a significant difference in test variables (p<0.05). Conclusion: Patients with Parkinson disease compared to healthy subjects face cognitive changes in sustained attention, and identification and evaluation of cognitive changes before and after treatment will be a considerable help in the rehabilitation of brain and a better quality of life for these patients.http://journals.sbmu.ac.ir/Neuroscience/article/download/9472/pdf_17
collection DOAJ
language English
format Article
sources DOAJ
author Afsaneh Zarghi
spellingShingle Afsaneh Zarghi
Continuous Performance Test for assessing cognition among patients with Parkinson diseases
International Clinical Neuroscience Journal
author_facet Afsaneh Zarghi
author_sort Afsaneh Zarghi
title Continuous Performance Test for assessing cognition among patients with Parkinson diseases
title_short Continuous Performance Test for assessing cognition among patients with Parkinson diseases
title_full Continuous Performance Test for assessing cognition among patients with Parkinson diseases
title_fullStr Continuous Performance Test for assessing cognition among patients with Parkinson diseases
title_full_unstemmed Continuous Performance Test for assessing cognition among patients with Parkinson diseases
title_sort continuous performance test for assessing cognition among patients with parkinson diseases
publisher Shahid Beheshti University of Medical Sciences
series International Clinical Neuroscience Journal
issn 2383-1871
2383-2096
publishDate 2015-04-01
description Background: Many patients with Parkinson diseases are faced with constant attention disorders and evaluation of these disorders in these patients is important. Methods: A cross-sectional study was conducted on 80 patients with Parkinson disease and 80 healthy Iranian people aged 40 to 70. All participants in the two groups of healthy and patients were examined by neurologists and psychiatrists. After completing the questionnaire, they were evaluated through computerized cognitive Continuous Performance Test. Results: There was significance difference between the two groups in age, sex and education status and in some variables of the test (p<0.05). Patients compared with healthy controls and showed a significant difference in test variables (p<0.05). Conclusion: Patients with Parkinson disease compared to healthy subjects face cognitive changes in sustained attention, and identification and evaluation of cognitive changes before and after treatment will be a considerable help in the rehabilitation of brain and a better quality of life for these patients.
url http://journals.sbmu.ac.ir/Neuroscience/article/download/9472/pdf_17
work_keys_str_mv AT afsanehzarghi continuousperformancetestforassessingcognitionamongpatientswithparkinsondiseases
_version_ 1725079089360928768